CalciMedica, Inc. (CALC )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol CALC
- Company CalciMedica, Inc.
- Price $1.66
- Changes Percentage 26.72
- Change 0.35
- Day Low $1.36
- Day High $1.68
- Year High $36
- Year Low $1.71
- Market Cap $5,478,882
- Price Avg 50 EMA (D) $2.94
- Price Avg 200 EMA (D) $7.54
- Exchange NASDAQ
- Volume 54,137
- Average Volume 98,146
- Open $1.4
- Previous Close $1.31
- EPS -1.33
- PE -1.31
- Earnings Announcement 2026-11-11 05:00:00
- Shares Outstanding $3,148,783
Company brief: CALCIMEDICA, INC. (CALC )
- Healthcare
- Biotechnology
- Dr. A. Rachel Leheny Ph.D.
- https://www.calcimedica.com
- US
- N/A
- 06-14-2023
- US38942Q2021
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.